West Pharmaceutical Services, Inc.
WST
$230.11
$6.382.85%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.25% | 6.38% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.25% | 6.38% | |||
| Cost of Revenue | -1.45% | 2.14% | |||
| Gross Profit | 3.36% | 15.09% | |||
| SG&A Expenses | 1.71% | -1.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -100.00% | -- | |||
| Total Operating Expenses | -0.55% | 1.33% | |||
| Operating Income | 3.06% | 28.73% | |||
| Income Before Tax | -0.89% | 26.43% | |||
| Income Tax Expenses | 13.58% | 47.95% | |||
| Earnings from Continuing Operations | -4.34% | 22.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.34% | 22.19% | |||
| EBIT | 3.06% | 28.73% | |||
| EBITDA | 2.71% | 22.86% | |||
| EPS Basic | -4.21% | 22.52% | |||
| Normalized Basic EPS | 4.56% | 26.52% | |||
| EPS Diluted | -3.62% | 22.52% | |||
| Normalized Diluted EPS | 4.56% | 26.69% | |||
| Average Basic Shares Outstanding | -0.14% | -0.27% | |||
| Average Diluted Shares Outstanding | -0.14% | -0.41% | |||
| Dividend Per Share | 5.00% | 0.00% | |||
| Payout Ratio | 0.10% | -0.19% | |||
